Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Showing 20 of 0 results

Not applicableStudy completedNCT01347801
What this trial is testing

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

Who this might be right for
Hypoglycaemia
Rigshospitalet, Denmark 40
Not applicableStudy completedNCT07625319
What this trial is testing

Gut Hormones and Nutritional Status After a Standardized Meal.

Who this might be right for
Obesity
Medical University of Bialystok 80
Testing effectiveness (Phase 2)Study completedNCT03225209
What this trial is testing

Medically Reproducing Bariatric Surgery

Who this might be right for
Type 2 Diabetes Mellitus
Moahad S Dar 5
Not applicableStudy completedNCT07031752
What this trial is testing

Plant-Based Meat Analogues and Human Health

Who this might be right for
Satiation, SatietyInsulinGlucose+4 more
Universidad de Extremadura 25
Not applicableLooking for participantsNCT07487467
What this trial is testing

Autologous SVF Therapy for Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Kaiser Clinic and Hospital 10
Post-approval studies (Phase 4)Looking for participantsNCT06706284
What this trial is testing

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Who this might be right for
Spinal Cord InjuriesType 2 Diabetes
Marzieh Salehi 50
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Testing effectiveness (Phase 2)Looking for participantsNCT07227948
What this trial is testing

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder

Who this might be right for
Cocaine Use Disorder
The University of Texas Health Science Center, Houston 75
Very early researchWithdrawnNCT04133922
What this trial is testing

Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesInsulin Sensitivity/Resistance
University of Virginia
Post-approval studies (Phase 4)UnknownNCT05005741
What this trial is testing

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Who this might be right for
Diabetes Mellitus, Type 2Overweight or Obesity
Second Xiangya Hospital of Central South University 120
Post-approval studies (Phase 4)Study completedNCT03151005
What this trial is testing

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Who this might be right for
Polycystic Ovary Syndrome (PCOS)OverweightObesity
Xinqiao Hospital of Chongqing 70
Not applicableStudy completedNCT02036372
What this trial is testing

Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type II
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 150
Post-approval studies (Phase 4)Study completedNCT04126603
What this trial is testing

Impact of Semaglutide on CD34+ EPC and Fat Derived MSC

Who this might be right for
Diabetes Mellitus, Type 2
Sabyasachi Sen 10
Not applicableStudy completedNCT02745470
What this trial is testing

Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain

Who this might be right for
Diabetes Mellitus
Seoul National University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05622123
What this trial is testing

BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation

Who this might be right for
Type 1 Diabetes
Radboud University Medical Center 20
Not applicableLooking for participantsNCT07075341
What this trial is testing

Healthy Living BEYOND Weight Study

Who this might be right for
Overweight or Obesity
American Heart Association 1,000,000
Large-scale testing (Phase 3)Study completedNCT00651105
What this trial is testing

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Who this might be right for
Type-2 DiabetesHealthy
Novartis 63
Not applicableStudy completedNCT05313529
What this trial is testing

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 396
Not applicableStudy completedNCT05535322
What this trial is testing

Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity

Who this might be right for
Type 2 DiabetesObesity
Ana Palanca 26,944
Post-approval studies (Phase 4)Ended earlyNCT03029351
What this trial is testing

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesKidney Diseases
University at Buffalo 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation